entertainment -WSS

entertainment

author：entertainment 2025-09-14 18:25:54 - browse：34132

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Inside the fall of star MIT scientist David Sabatini

explore

WSS

Inside the fall of star MIT scientist David Sabatini

Listen: Vivek Ramaswamy's star turn & leaky drug data

4th of July breaks record for highest global temperature ever measured

Health officials lay out plans to cope with respiratory virus season

Did the public have the right to know Arthur Ashe had AIDS?

CDC says it’s too soon to assess risk posed by Covid subvariant

entertainment

entertainment

knowledge

Walensky prepares to leave CDC — and Congress — behind

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

PBMs are inflating the cost of generic drugs. They must be reined in

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Option Care buys Amedisys in $3.6 billion home care deal

Cancer drug shortages should be causing more outrage

National associations that represent hospice owe an apology

Medicare proposal to cover medical devices draws a mixed reaction

These geoengineering technologies could help combat the climate crisis, scientists say

knowledge

Former Pear Therapeutics executives start new VC firm

California store owner shot dead in dispute over displaying Pride flag: Police

Make 'food is medicine' a key part of White House nutrition meeting

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Australia's humpback populations rebound raising hopes of marine scientists

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

hotspot

explore

focus

knowledge